The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > BioNumerik Pharmaceuticals, Inc.

BioNumerik Pharmaceuticals, Inc.
 PROFILE
BioNumerik Pharmaceuticals crunches the numbers to develop drugs that fight cancer and the side effects associated with many therapies. The firm's "mechanism-based" approach relies heavily on computer models and simulations to identify promising drug candidates; it has access to supercomputer technology through an alliance with Cray Inc. The company's lead product candidate, BNP7787 (to prevent nerve and kidney damage caused by cancer treatments), has been granted fast-track development status from the FDA. Nearly all of the firm's revenue comes from a joint venture with an affiliate of leading Japanese drugmaker Takeda Chemical Industries. Founder and chairman Frederick Hausheer owns nearly a third of BioNumerik.

 COMPETITION
ILEX Oncology, Inc. (ILXO)
Sepracor Inc. (SEPR)

 FINANCIAL OVERVIEW
Fiscal Year-End: March
2000 Sales (mil.): 0.30
1-Yr. Sales Growth: (99.7)%
Employees: 38
Revenue per employee: $7,894.74

 KEY PEOPLE
• Frederick H. Hausheer
    CEO
• Steven W. Riebel
    CFO

 CONTACT INFO
8122 Datapoint Dr., Ste. 1250
San Antonio, TX 78229
US
Phone: 210-614-1701
Fax: 210-615-8030

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001